News | March 28, 2024
WuXi Biologics breaks ground on CRDMO Center in Singapore
The CRDMO site will add 120,000L manufacturing capacity to WuXi Biologics’ global network
The CRDMO site will add 120,000L manufacturing capacity to WuXi Biologics’ global network
Elegen is the only DNA manufacturer delivering the unique combination of complexity, length and NGS-verified accuracy within days
AbCellera will receive an upfront payment and is eligible to receive additional milestone payments
Acquisition of exclusive commercialization rights for European markets
The National One Health Mission will help India to achieve integrated disease control and pandemic preparedness
Cipla completes transfer of Generics Business Undertaking
The objective of GCMC is well aligned to WHO’s call to action and India’s National Biotechnology Development Strategy
Orchid is the first company from India, ever to have invented a product which has received a New Drug Approval (NDA) from USFDA
Commercialization of rPEG lipids designed to improve immunogenicity profile for nucleic acid delivery
he lower sales in the current quarter are mainly on account of a one?time impact on the company’s India business
Subscribe To Our Newsletter & Stay Updated
